Litigation Details for Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
✉ Email this page to a colleague
Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-05-04 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Jennifer L. Hall |
Jury Demand | None | Referred To | |
Parties | EAGLE PHARMACEUTICALS, INC. | ||
Patents | 8,436,190; 8,445,524; 8,609,863; 8,669,279; 8,791,270; 8,883,836; 8,895,756; 9,533,955; 9,572,887 | ||
Attorneys | Robert F. Hartsmith | ||
Firms | Shaw Keller LLP, DE | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Teva Pharmaceuticals International GmbH v. BendaRx USA
Biologic Drugs cited in Teva Pharmaceuticals International GmbH v. BendaRx USA
Details for Teva Pharmaceuticals International GmbH v. BendaRx USA (D. Del. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2024-03-08 | 50 | Answer to Amended Complaint AND Counterclaim | actions for patent infringement against BendaRx for infringement of U.S. Patent Nos. 8,436,190 (the “’190…INFRINGEMENT BY BENDARX OF U.S. PATENT NO. 8,436,190 UNDER 35 U.S.C. SECTION 271(E)(2) … BY BENDARX OF U.S. PATENT NO. 8,436,190 73. BendaRx incorporates …-infringement and/or invalidity of U.S. Patent Nos. 8,436,190 …the ’190 Patent, ’524 Patent, ’863 Patent, ’279 Patent, ’270 Patent, ’836 Patent, ’756 Patent, ’955 Patent | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |